Altman and Amodei urge DNA tracking to prevent AI bioweapons
- Source
- Wired
- Time
- 2:51 AM
- Weight
- 94/100
Sam Altman and Dario Amodei, the CEOs of OpenAI and Anthropic, have voiced concerns regarding the potential for artificial intelligence to be utilized in the development of biological weapons. The executives warn that while AI has the potential to accelerate medical breakthroughs, it could also lower the technical barriers for malicious actors to design or enhance dangerous pathogens.
They emphasize that the intersection of advanced large language models and synthetic biology requires immediate regulatory attention to prevent catastrophic outcomes. To address these security risks, Altman and Amodei are advocating for a universal screening system for DNA synthesis orders.